Clinical Trials Logo

Clinical Trial Summary

study the effect of mefanamic acid or valproate on ciprofol


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05181007
Study type Interventional
Source Haisco Pharmaceutical Group Co., Ltd.
Contact Xu Wang
Phone 13671811021
Email [email protected]
Status Recruiting
Phase Phase 1
Start date December 17, 2021
Completion date December 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04840862 - Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor Phase 4
Completed NCT04557397 - Fruquintinib CYP3A Inhibitor and Inducer Study Phase 1
Recruiting NCT05137600 - A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects Phase 1
Completed NCT04606537 - Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects Phase 1
Recruiting NCT04939467 - Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers Phase 1
Completed NCT04542252 - Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects Phase 1
Completed NCT05123820 - Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470 Phase 1
Active, not recruiting NCT04814498 - Drug-Drug Interaction (DDI) Study in Healthy Volunteers Phase 1
Completed NCT01350921 - Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers Phase 1
Completed NCT03103568 - A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers Phase 1
Completed NCT04840641 - Flucloxacillin as an Inducer of CYP-enzymes Phase 1
Recruiting NCT04776499 - Study of Possible Effects of the Drugs Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers Phase 1
Completed NCT03909529 - Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug) Phase 1
Enrolling by invitation NCT04984538 - Implementation of a Pharmacist-led Pharmacogenomic Clinical Service